Benegrastim

Unassigned

New Medicines

Severe neutropenia, resulting from chemotherapy

Information

New molecular entity
Generon
Generon

Development and Regulatory status

Phase III Clinical Trials
Phase III Clinical Trials
Phase III Clinical Trials

Category

Recombinant human Granulocyte Colony Stimulating Factor (rhG-CSF). A dimeric recombinant fusion protein. consists of two granulocyte colony stimulating factor (G-CSF) molecules at the N-terminal of IgG2-Fc fragments
Recombinant human granulocyte-colony stimulating factor (rhG-CSF) is given subcutaneously and stimulates the production of neutrophils in the bone marrow. It may reduce the duration of chemotherapy-induced neutropenia and thereby reduce the incidence of associated sepsis [2].
Severe neutropenia, resulting from chemotherapy
Subcutaneous injection